Allergy vaccine - Acambis

Drug Profile

Allergy vaccine - Acambis

Alternative Names: Antiallergy vaccine - Acambis

Latest Information Update: 23 Jul 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Birmingham
  • Class Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Food hypersensitivity; Seasonal allergic rhinitis

Most Recent Events

  • 23 Jul 1999 Discontinued-I for Seasonal allergic rhinitis in Poland (Unknown route)
  • 23 Jul 1999 Discontinued-II for Food allergy in Poland (Unknown route)
  • 26 Feb 1998 Phase-I clinical trials for Seasonal allergic rhinitis in Poland (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top